IT IS UNLAWFUL TO CONSUMMATE A SALE OR TRANSFER OF THIS SECURITY, OR ANY INTEREST THEREIN, OR TO RECEIVE ANY CONSIDERATION THEREFOR, WITHOUT THE PRIOR WRITTEN CONSENT OF THE COMMISSIONER OF CORPORATIONS OF THE STATE OF CALIFORNIA, EXCEPT AS PERMITTED...Agouron Pharmaceuticals Inc • May 27th, 1997 • Pharmaceutical preparations
EXHIBIT 4.1 AGOURON PHARMACEUTICALS, INC. andRights Agreement • January 19th, 1999 • Agouron Pharmaceuticals Inc • Pharmaceutical preparations • California
Exhibit 99.3 AGOURON PHARMACEUTICALS, INC. (a California Corporation) 1998 EMPLOYEE NON-STATUTORY STOCK OPTION AGREEMENT This Option Agreement is entered into between Agouron Pharmaceuticals, Inc., a California corporation and the Optionee whose name...Stock Option Agreement • February 19th, 1998 • Agouron Pharmaceuticals Inc • Pharmaceutical preparations • California
EXHIBIT 10.67 AGOURON PHARMACEUTICALS, INC. (a California Corporation) 1990 INCENTIVE STOCK OPTION AGREEMENT This Option Agreement is entered into between Agouron Pharmaceuticals, Inc., a California corporation and the Optionee whose name appears on...Incentive Stock Option Agreement • January 28th, 1997 • Agouron Pharmaceuticals Inc • Pharmaceutical preparations • California
LETTER OF INTENTAgouron Pharmaceuticals Inc • June 25th, 1997 • Pharmaceutical preparations • California
PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED (DESIGNATED BY AN ASTERISK (*) AND WHITE SPACE) AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT DATED AUGUST 4, 1998; FILE NO. 0-15609 COMMON...Common Stock Purchase Agreement • October 28th, 1998 • Agouron Pharmaceuticals Inc • Pharmaceutical preparations • California
AMENDMENT TO THE VIRACEPT (Nelfinavir Mesylate) LICENSE AGREEMENT This Amendment ("Amendment") to the VIRACEPT (Nelfinavir Mesylate) License Agreement ("the Agreement"), effective as of this 1st day of May, 1998 ("Effective Date"), is between Agouron...License Agreement • August 4th, 1998 • Agouron Pharmaceuticals Inc • Pharmaceutical preparations
THYMITAQLicense Agreement • August 21st, 1997 • Agouron Pharmaceuticals Inc • Pharmaceutical preparations • California
Exhibit 10.74 CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS AGREEMENT PURSUANT TO AN APPLICATION DATED JANUARY 27, 1997, AS SEPARATELY FILED WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL PORTIONS ARE INDICATED WITH AN...Confidential Treatment • January 28th, 1997 • Agouron Pharmaceuticals Inc • Pharmaceutical preparations • California
AMERICAN INDUSTRIAL REAL ESTATE ASSOCIATION STANDARD INDUSTRIAL/COMMERCIAL SINGLE-TENANT LEASE - NET (DO NOT USE THIS FORM FOR MULTI-TENANT BUILDINGS) 1. Basic Provisions ("Basic Provisions") 1.1 Parties: This Lease ("Lease"), dated for reference...Agouron Pharmaceuticals Inc • August 21st, 1997 • Pharmaceutical preparations • California
VIRACEPT (NELFINAVIR MESYLATE)Trademark License Agreement • August 21st, 1997 • Agouron Pharmaceuticals Inc • Pharmaceutical preparations • California
PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED (DESIGNATED BY AN ASTERIX (*) AND WHITE SPACE) AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT DATED AUGUST 21, 1997; FILE NO. 0-15609 SECOND...Development and License Agreement • August 21st, 1997 • Agouron Pharmaceuticals Inc • Pharmaceutical preparations
ARTICLE 1Agreement and Plan of Reorganization • June 4th, 1997 • Agouron Pharmaceuticals Inc • Pharmaceutical preparations • California
1990 NON-STATUTORY STOCK OPTION AGREEMENT FOR EMPLOYEES, OFFICERS AND DIRECTORSOption Agreement • January 28th, 1997 • Agouron Pharmaceuticals Inc • Pharmaceutical preparations • California
EXHIBIT 10.69 AGOURON PHARMACEUTICALS, INC. (a California Corporation) 1990 NON-STATUTORY STOCK OPTION AGREEMENT FOR CONSULTANTS This Option Agreement is entered into between Agouron Pharmaceuticals, Inc., a California corporation and the Optionee...Option Agreement • January 28th, 1997 • Agouron Pharmaceuticals Inc • Pharmaceutical preparations • California
PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED (DESIGNATED BY AN ASTERISK (*) AND WHITE SPACE) AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT DATED AUGUST 4, 1998; FILE NO. 0-15609...License and Supply Agreement • October 28th, 1998 • Agouron Pharmaceuticals Inc • Pharmaceutical preparations
EXHIBIT 10.64 SUBLEASEAgouron Pharmaceuticals Inc • January 28th, 1997 • Pharmaceutical preparations
EXHIBIT 10.6 Form of Employment Agreement dated January 26, 1999 executed with Peter Johnson, Marvin R. Brown, Gary E. Friedman, Barry D. Quart and R. Kent Snyder EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (this "Agreement"), dated January 26,...Employment Agreement • February 5th, 1999 • Agouron Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
EXHIBIT 10.4 AGREEMENT AND PLAN OF MERGER DATED AS OF JANUARY 26, 1999Agreement and Plan of Merger • February 5th, 1999 • Agouron Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
EXHIBIT 10.5 STOCK OPTION AGREEMENT STOCK OPTION AGREEMENT, dated as of January 26, 1999 (the "Agreement"), by and between Agouron Pharmaceuticals, Inc., a California corporation ("Issuer"), and Warner-Lambert Company, a Delaware corporation...Stock Option Agreement • February 5th, 1999 • Agouron Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
INCENTIVE STOCK OPTION _________________________, Optionee: ALANEX CORPORATION (the "Company"), pursuant to its 1996 Equity Incentive Plan (the "Plan"), has granted to you, the optionee named above, an option to purchase shares of the common stock of...Incentive Stock Option • May 27th, 1997 • Agouron Pharmaceuticals Inc • Pharmaceutical preparations
NONSTATUTORY STOCK OPTION _____________________________, Optionee: ALANEX CORPORATION (the "Company"), pursuant to its 1996 Equity Incentive Plan (the "Plan"), has granted to you, the optionee named above, an option to purchase shares of the common...Nonstatutory Stock Option • May 27th, 1997 • Agouron Pharmaceuticals Inc • Pharmaceutical preparations
Rights Agent Rights AgreementRights Agreement • November 8th, 1996 • Agouron Pharmaceuticals Inc • Pharmaceutical preparations • California
W I T N E S S E T H:Rights Agreement • December 20th, 1996 • Agouron Pharmaceuticals Inc • Pharmaceutical preparations
PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED (DESIGNATED BY AN ASTERISK (*) AND WHITE SPACE) AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT DATED AUGUST 4, 1998; FILE NO. 0-15609...Agouron Pharmaceuticals Inc • August 7th, 1998 • Pharmaceutical preparations
RECITALSAgouron Pharmaceuticals Inc • October 28th, 1998 • Pharmaceutical preparations
LEASE AMENDMENT NO. 3Agouron Pharmaceuticals Inc • January 28th, 1997 • Pharmaceutical preparations
EXHIBIT 10.65 AGREEMENT10.65 Agreement • January 28th, 1997 • Agouron Pharmaceuticals Inc • Pharmaceutical preparations • California
EXHIBIT 10.41 PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED (DESIGNATED BY AN ASTERISK (*) AND WHITE SPACE) AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT DATED January 14, 1998; FILE...Agouron Pharmaceuticals Inc • January 14th, 1998 • Pharmaceutical preparations
